- 2021 (4) ▼
- 2020 (65) ▼
- 2019 (41) ▼
- 2018 (21) ▼
Our latest newsletter is now available - read about the IGA's plans to expand its global reach and its partnership with AVROBIO to explore gene therapy as a potential treatment for Gaucher patients here
The IGA are excited to be working in partnership with Avrobio to explore gene therapy as a potential treatment for Gaucher patients.
AVROBIO, a leader in lentiviral-based gene therapies, is a clinical stage company developing …
We are delighted to announce that Kristiyan Dimitrov, the IGA representative for the Bulgarian Gaucher Association, has agreed to join the IGA Board as a co-opted member.
Kristiyan was one of the first patients diagnosed in Bulgaria and when …